Weight Loss
3 available clinical trials fall under the “Weight Loss” category.
SETMELANOTIDE RM-493-035
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study: 5 Independent Sub-studies of Setmelanotide in Patients with POMC, PCSK1, LEPR, SRC1, SH2B1, and PCSK1 N221D Gene Defects in the Melanocortin-4 Receptor Pathway
Change in Fructosamine before and one month after the bariatric surgery predict weight loss, six months after surgery.
Evaluation of Group Obesity Therapy Implementation using Implementation Framework